baber/WOPTO huggingface dataset:
Patent AU-2012311537-A1 (AU)
Title: Device and method for routing secure communication streams between remote sites
Inventor: BOUET MATHIEU
IPC: H04L45/50
Filed: 2012-09-20
Abstract: Device (D) for interconnecting and routing between a remote local network (E_201 ) and at least one transport network (T_204, T_205, T_206) characterised in that it comprises: • first means (311) capable of selecting, for a communication stream coming from said source local network (E_201), at least one path to the remote network (E_203) for which it is intended and associating this path with a marking value (X), • means (317) of inserting the marking value (X) into a header field of the packets of said stream, • means (331) of encrypting the entirety of said stream except the header fields, • second means (321) capable of switching said encrypted stream towards the transport network (T_204) directly connected to said source local network (E_201) and located on the selected path, according to the marking value (X) read in the header field of said packets, • a gateway (341) for communicating, to said second means (342), the association between the marking value (X) and the switch to apply according to the path selected by said first means (311).
Patent AU-2012316397-A1 (AU)
Title: Methods for treatment of diseases
Inventor: KEENE JEFFREY L
IPC: A61P29/00
Filed: 2012-09-24
Abstract: The present disclosure relates to methods of treating a range of diseases or conditions. The methods involve administration of a superoxide dismutase mimetic
Patent AU-2012324543-A1 (AU)
Title: Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
Inventor: SCHERER WARREN J
IPC: A61K31/4164
Filed: 2012-10-12
Abstract: The present invention relates to a method of reducing cutaneous facial flushing caused by systemic use of phosphodiesterase type 5 (PDE5) inhibitors by topical facial dermatological application of an effective dose of a composition comprising at least one alpha adrenergic receptor agonist.
Patent AU-2012367317-A1 (AU)
Title: Device for measuring electrical current and method of manufacturing the same
Inventor: KESLER JAMES R
IPC: H01F27/28
Filed: 2012-06-06
Abstract: Disclosed herein are embodiments of devices for measuring electrical current and related systems and methods for forming and using such devices. According to certain embodiments, devices according to the present disclosure may comprise Rogowski coils. Also disclosed are systems and methods for forming a current measuring device using a bobbin that may allow for the use of a continuous length of wire for all windings associated with the current measuring device. Automated manufacturing techniques may be utilized to facilitate the manufacture of devices for measuring electrical current and/or may reduce the cost of such devices. Various embodiments disclosed herein include the use of a bobbin that may be selectively configured between a linear configuration and a closed configuration. One or more current sensors disclosed herein may be utilized in connection with a motor management relay or other type of intelligent electronic device.
Patent AU-2012388949-A1 (AU)
Title: Material structure prediction apparatus, product manufacturing method and material structure prediction method
Inventor: SANO MITSUHIKO
IPC: G01N33/20
Filed: 2012-08-31
Abstract: A material organization predict device (1) comprises: a temperature calculation unit (103) which, on the basis of a temperature condition for applying a temperature change to a material, calculates temperatures at a plurality of calculation points within a region which is to be calculated of a material; a nucleation iteration calculation unit (104) which, on the basis of the temperatures at the plurality of calculation points, calculates nucleation iterations within the region to be calculated; a nucleation unit (105) which, on the basis of the nucleation iterations, determines from the plurality of calculation points a precipitation phase generation point which generates a precipitation phase nucleus; a grain growth calculation unit (106) which, with respect to the precipitation phase generation point, calculate grain growth in the precipitation phase; and, on the basis of the calculated grain growth of the precipitation phase, predicts the organization of the material.
Patent AU-2012392518-A1 (AU)
Title: Computing systems and methods for controlling a computing system
Inventor: WILSON JOHN ALEXANDER
IPC: G06F1/32
Filed: 2012-10-16
Abstract: According to various embodiments, a computing system may be provided.. The computing system may include: a circuit configured to operate at a plurality of operation frequencies; a graphics output configured to output image data for display; a rate determiner configured to determine a frame rate of the graphics output; and a frequency setter configured to set an operation frequency of the circuit based on the determined frame rate.
Patent WO-2013155567-A1 (WO)
Inventor: AYERS KATIE LOUISE
IPC: C12N15/09
Filed: 2013-04-19
Abstract: La présente invention concerne des méthodes de manipulation de la détermination du sexe chez des animaux et de nouveaux gènes et de nouvelles protéines identifiés comme jouant un rôle dans la détermination du sexe. Dans un exemple, la présente invention fait appel à des méthodes de manipulation de la détermination du sexe chez des espèces aviaires.
Patent WO-2013177619-A1 (WO)
Inventor: BUCKNELL BENJAMIN GEORGE WENTWORTH
IPC: G06Q40/04
Filed: 2013-05-30
Abstract: A method/system for pricing and allocating identified securities of a company on a registered securities exchange, as opposed to off-market. A host computer system or computer receives bid data indicative of one or more bids for the identified securities from one or more eligible investors. Determination of at least one price of the identified securities and a preferential allocation of at least some of the identified securities to eligible investors is performed at least partially based on bids that are higher than the determined match price or bids that are received prior to a specified time or times. The preferential allocation of at least some of the identified securities to at least some of the eligible investors is part of the bookbuild performed on the registered securities exchange. The bids are able to be accepted in real time by an issuer or seller of the identified securities.
Patent WO-2014056029-A1 (WO)
Title: Complément alimentaire pour animal comprenant de la ractopamine et de la caféine
Inventor: LUXFORD BRIAN GERARD
IPC: A23K1/18
Filed: 2013-10-08
Abstract: L'invention concerne un complément alimentaire pour animal, comprenant une combinaison synergique de ractopamine et de caféine, et un procédé d'accroissement de l'indice de consommation d'un cochon à l'aide du complément alimentaire pour animal.
Patent AU-2013203653-A1 (AU)
Title: Cell culture improvements
Inventor: SCHULZ CHRISTOF
IPC: C12N5/02
Filed: 2013-04-11
Abstract: CELL CULTURE IMPROVEMENTS The invention describes improved methods and compositions for producing a recombinant protein, e.g., an antibody, in mammalian cell culture. In addition, the invention provides improved cell culture media, including improved production media, feed solutions, and combination feeds, which may be used to improve protein productivity in mammalian cell culture.
Patent AU-2013203874-A1 (AU)
Title: Apparatus for exhausting air
Inventor: BADENHORST SEAN MICHAEL JOHL
IPC: F24F7/02
Filed: 2013-02-18
Abstract: Disclosed herein is an apparatus for exhausting air from a space. The space may comprise the interior space(s) of buildings such as hospitals, enclosed shopping malls, warehouses, 5 factories, high rise buildings, etc. The apparatus comprises at least a first discharging arrangement in the form of return and supply air ducts of an air handling unit (AHU). The apparatus also comprises a second discharging arrangement in the form of a smoke exhaust box. The return air duct is arranged to receive an air stream discharged from the space and is able to be isolated from the smoke exhaust box. Upon isolation of the return air duct, the 10 smoke exhaust box is able to receive and discharge an air stream (e.g. a smoke-filled or contaminated air stream) from the space.
Patent AU-2013212888-A1 (AU)
Title: Plant disease control composition
Inventor: IWATA ATSUSHI
IPC: A01N37/30
Filed: 2013-01-21
Abstract: To provide a plant disease control composition having excellent control effect against plant diseases. A plant disease control composition comprising an amide compound represented by formula (I) : wherein each symbol is as defined in the description, and fludioxonil has excellent control effect against plant diseases.
Patent AU-2013242080-A1 (AU)
Title: Use of oxazolines as aroma/flavour precursors
Inventor: BLANK IMRE
IPC: A23L27/21
Filed: 2013-03-19
Abstract: The present invention relates to compounds based on an oxazoline moiety which liberate Strecker aldehydes under mild and controllable conditions. In addition the invention relates to food products comprising such compounds, and uses of such compounds.
Patent AU-2013246435-A1 (AU)
Title: A novel cholesterol metabolite, 5-cholesten-3beta- 25-diol, disulfate (2HCDS) for therapy of metabolic disorders, hyperlipidemia, diabetes, fatty liver diseases and atherosclerosis
Inventor: REN SHUNLIN
IPC: C07J31/00
Filed: 2013-03-15
Abstract: 5-cholesten, 3β, 25-diol, disulfate (25HCDS) has been found to be an authentic PPAR
Patent AU-2013249767-A1 (AU)
Title: Multiplex immunoassay for rheumatoid arthritis and other autoimmune diseases
Inventor: BINDER STEVEN R
IPC: G01N33/53
Filed: 2013-03-21
Abstract: Rheumatoid arthritis and other autoimmune diseases are diagnosed by multiplex assays for antibodies to a panel of antigens that includes cyclic citrullinated peptide and at least five members of a list that includes BRAF1 506-525, BRAF2 656-675, Vimentin (protein) citrullinated, Vimentin 415-433 cit cyclic, Vimentin 58-77 cit3 cyclic, Clusterin 231-250 cit sm1 cyclic, Fibrinogen A 556-575 cit sm cyclic, Fibrinogen A 616-635 cit sm cyclic, Histones2A H2A/a 1-20 cit sm2 cyclic, Filaggrin 48-65 cit2v1 cyclic, BRAF (catalytic domain from v raf murine sarcoma viral oncogene homologue B1, amino acids
Patent AU-2013254951-A1 (AU)
Title: Image inspecting system and recording material processing device
Inventor: HIRAMATSU TAKASHI
IPC: B41J11/00
Filed: 2013-11-08
Abstract: A recording material processing device, includes: an accumulation unit that is accumulated with a plurality of recording materials each of which is a recording material formed with an image by an image forming unit and inspected by an inspection unit, in which the image forming unit that forms the image on the recording material based on original image data; and a processing unit that removes the recording material which was determined to have a defect which occurred in the image by the inspecting unit, among the plurality of recording materials and adds a new recording material on which a same image is formed by the image forming unit , to the plurality of recording materials, the same image being based on the original image data of the image formed on the defective recording material.
Patent AU-2013255438-A1 (AU)
Title: Handheld tracking systems and devices for aligning implant systems during surgery
Inventor: DUSHYANT ANANTHARAMAN
IPC: A61B19/00
Filed: 2013-05-01
Abstract: The present invention discloses handheld tracking systems and devices comprising of at least one handheld tracking device for intra-operative aligning or positioning of surgical implant systems and instruments with reference to the anatomy of a patient. The handheld tracking system further comprises of at least one trackable element. The handheld device is mounted at the proposed implantation site using the holding means while trackable element(s) is/are mounted at predetermined location(s) such that data from said deployed trackable element(s) relating to the position of the patient and the surgical instruments are input continuously into the handheld devices. The handheld device then processes the data on the basis of pre-loaded preoperative scanned images in the processing means to monitor the accurate placement of said implant system onsite in sterile environment.
Patent AU-2013270602-A1 (AU)
Title: Method and systems for providing an infusion device interface
Inventor: TASHJIAN PAUL
IPC: A61M5/00
Filed: 2013-12-13
Abstract: Abstract An infusion device (100) comprising an infuser base (105), a cannula (115) and a ferrule (120). The infuser base (105) having a bore (104) extending therethrough, the 5 bore (104) having a distal and proximal ends the proximal end having an inside first diameter. A flange (135) extends radially outward from the cannula proximal end. The cannula (115) is positioned in the bore (104) such that the flange (135) is positioned adjacent the shoulder (109). The ferrule (120) has an insertion portion (122), having an outside second diameter which is substantially equal to the first 10 diameter, and a tapered portion (125) extending from the insertion portion (122). The ferrule (120) is positioned in the bore (104) such that the insertion portion (122) and a portion of the tapered portion (125) are received in the cannula proximal end and the flange (135) is compressed between the shoulder (109) and the tapered portion (125) to define a seal (160) between the cannula (115) and the ferrule (120).
Patent AU-2013288383-A1 (AU)
Title: Popelova, AndreaLipidated peptides as anti-obesity agents
Inventor: MALETINSKA LENKA
IPC: C07K14/435
Filed: 2013-07-11
Abstract: Lipidated peptides, analogs of both forms of the prolactin-releasing peptide, PrRP31 and PrRP20, represent anorexigenic compounds that lower food intake and function in the brain after peripheral administration. The analogs PrRP31 and PrRP20 lipidated at the N-terminus by myristic or palmitic acids bind with high affinity to the endogenous receptor GPR10 in the rat pituitary cell line RC-4B/C and CHO cell line with transfected human receptor. These lipidated peptides also significantly decrease, in a dose-dependent manner, the food intake in fasted mice and have similar effects in comparable doses as centrally administered natural PrRP31, these effects are, however, stronger and longer lasting. Lipidation of an effective anorexigenic neuropeptide PrRP induces a central effect after peripheral administration and thus makes the lipidated analogs of PrRP a promising anti-obesity drug.
Patent AU-2013296142-A1 (AU)
Title: Technologies, methodologies, and computer implemented frameworks configured to enable delivery of electronic messages to recipients
Inventor: STEVENS GLEN
IPC: H04M11/08
Filed: 2013-07-24
Abstract: Described herein are technologies, methodologies, and computer implemented frameworks configured to enable delivery of electronic messages to recipients. For example, embodiments include the likes of systems and methods for coordinating message delivery, systems and methods for automated direct delivery of audio messages to voicemail accounts, a multi-modem device configured to enable automated delivery of audio messages directly to voicemail accounts, an Automated Voice Messaging (AVM) Server, and a mobile app configured to enable a user to communicate an audio message directly to a voicemail account. Embodiments of the invention have been particularly developed for operation in the context of technology for coordinating the delivery of voicemail-type messages to recipients, for example in the context of a message coordination server and API interface.
Patent AU-2013299717-A1 (AU)
Title: Carbohydrate conjugated RNA agents and process for their preparation
Inventor: JAYAPRAKASH NARAYANANNAIR K
IPC: A61K47/48
Filed: 2013-08-06
Abstract: This disclosure relates to an improved process for the preparation of carbohydrate conjugates. The disclosure also relates to carbohydrate conjugated iRNA agents comprising these carbohydrate conjugates, which have improved purity and are advantageous for the
Patent AU-2013326881-A1 (AU)
Title: Use of a PVDF membrane to purify cell-binding agent cytotoxic agent conjugates
Inventor: CHEN XIAOXI KEVIN
IPC: B01D39/14
Filed: 2013-10-04
Abstract: The invention provides processes for preparing purified cell-binding agent cytotoxic agent conjugates comprising subjecting a mixture comprising a cell-binding agent cytotoxic agent conjugate and one or more impurities to a polyvinyl difluoride (PVDF) membrane to remove at least a portion of the impurities from the mixture, thereby providing a purified cell-binding agent cytotoxic agent conjugate.
Patent AU-2013353723-A1 (AU)
Title: Novel selective androgen receptor modulators
Inventor: ANDERSON JAMES THOMAS
IPC: C07C255/58
Filed: 2013-11-25
Abstract: The present invention relates to a compound of Formula 1, 2 or 3: wherein A is N or –CR
Patent AU-2013382188-A1 (AU)
Title: Collapsible stackable container with self-contained attachment members
Inventor: BRENNAN JAMES F
IPC: B65D6/18
Filed: 2013-03-13
Abstract: A container may be configured to be operable between a collapsed configuration and an erected configuration. The container may include a base that supports a first attachment member. The container may include a roof that supports a second attachment member. The first and second attachment members may be spaced apart from each other when the container is in the erected configuration. The first and second attachment members may be configured to allow the roof to be secured to the base when the container is in the collapsed configuration. A hinge assembly that may be used with the collapsible container may include a pivoting component, an attachment member that supports the pivoting component, and a securement member. The attachment member may cooperate with the securement member to secure the pivoting component in an upright orientation.
Patent WO-2014201496-A1 (WO)
Inventor: ANTHONY JOHN SAMUEL
IPC: G06Q20/22
Filed: 2014-06-17
Abstract: A service provider terminal including: a member ID input module for receiving data indicative of a user member ID associated with a loyalty program, wherein the user accumulates a plurality of member points through performing one or more point earning activities offered by the loyalty program; a service provider input module for receiving data indicative of a user service provider ID associated with a service account; and a computation module for reducing the member points by a predetermined number of points, if the number of member points is greater than or equal to the predetermined number of points, thereby to allow the user to proceed with a service transaction provided by the service provider terminal without a monetary service fee being charged to the service account.
Patent WO-2014179840-A1 (WO)
Title: Applicateur d'agent non invasif
Inventor: UNGER HARRY
IPC: A61M37/00
Filed: 2014-05-06
Abstract: La présente invention concerne un vecteur d'agent pour administrer un agent aux tissus biologiques. Le vecteur d'agent comprend un corps de vecteur d'agent configuré pour retenir l'agent à l'intérieur du corps de vecteur d'agent et a une surface en contact avec le tissu pour se mettre en prise avec les tissus traités. Le corps peut comprendre des microcanaux pour le passage de l'agent, et la surface en contact avec les tissus peut comprendre des micro-aiguilles. L'administration de l'agent aux tissus est réalisée par un stimulus de transport qui entraîne le transport de l'agent par le vecteur d'agent. Le stimulus de transport peut être l'iontophorèse ou la sonophorèse, qui améliorent ou permettent aussi la pénétration de l'agent dans le tissu. L'application du stimulus de transport entraîne le transport dans l'agent par le corps de vecteur d'agent vers la surface en contact avec le tissu.
Patent AU-2014202378-A1 (AU)
Title: Motorized hand tool apparatus and assembly method
Inventor: BACHMAN JOSE R
IPC: B25B21/00
Filed: 2014-05-01
Abstract: Abstract A motorized hand tool such as a cordless ratchet wrench is configured for reducing assembly and disassembly processes. The motorized hand tool includes a motor end plate that may be fastened to a drive member such as a ratchet head assembly without the use of fasteners 5 or assembly tooling such as presses, fixtures or hammers. A flange on the motor end plate can pass through a keyway in a periphery of the ratchet head assembly and may be then be rotated out of the keyway and into a peripheral slot of the ratchet head assembly. A rib protruding inwardly from a clamshell housing portion of the tool closes the keyway to prevent the flange on the motor end plate from rotating back into the keyway. -------
Patent AU-2014239974-A1 (AU)
Title: Transfer set
Inventor: KRAMER PETER
IPC: A61J1/20
Filed: 2014-03-14
Abstract: A transfer set generally includes an outer sleeve configured for connecting an inner sleeve to a vial such that a passage of the inner sleeve is disposed above a stopper of the vial. The transfer set further includes a cap configured for insertion into the outer sleeve such that the cap is connected to the outer sleeve and is detachable from the outer sleeve via rotation of the cap relative to the outer sleeve. The cap has an interior space and a cam disposed within the interior space, wherein the inner sleeve, and a spike within the inner sleeve, extend into the interior space when the cap is connected to the outer sleeve, and wherein, as the cap rotates relative to the outer sleeve for detachment of the cap from the outer sleeve, the cam interacts with the follower to translate the spike toward the stopper for puncturing the stopper.
Patent AU-2014256750-A1 (AU)
Title: Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
Inventor: REN BO
IPC: C07D209/04
Filed: 2014-04-14
Abstract: Disclosed are substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-one compounds, pharmaceutical compositions comprising at least one such4substituted5-(3,5-dimethylisoxazol- 4-yl)indoline-2-one compound processes for the preparation thereof,and the use thereof for inhibiting BET family of bromodomains and for treating disorders mediated thereby,such as certain cancers.
Patent AU-2014280959-A1 (AU)
Title: Process For The Complex Processing Of Bauxite
Inventor: WELTER ALEXANDER
IPC: C22B3/32
Filed: 2014-12-24
Abstract: Abstract The process for complex processing of bauxite relates to the metallurgy of non ferrous metals, especially the field of producing alumina from bauxites, and is 5 particularly effective when processing siderite-containing bauxites. The industrial result when processing bauxite is the production of alumina and a metallurgical iron ore concentrate as well as a conditioned iron ore concentrate. The hydrochemical process extracts iron compounds from the bauxite to form an iron-ore concentrate that is suitable for the production of steel, wherein the 10 bauxite is completely desideritised and then further processed into alumina using known processes. The separation of the iron compounds at the beginning of the process and the desideritisation of the bauxite ensure an increased efficiency for the production of alumina. bauxite milling and Fe extraction Bayer enriched flrto ftepl Process bauxite (solid flrto ftepl phase) solution of the iron chelate (liquid phase) NaHCO sodumhyroenNeutralisation at pH 7 - 8 NaC0 carboaluminate (solid filtration of the pulp calcination solution of the iron chelate (liquid phase) nre-extraction of iron at pH 12 g 1Fe(OH)3-iron ore filtration of the pulp -Wconcentrate (solid (: phase) mother liquor of the Chelate (liquid phase) concentration by evaporation cooling CO2 ,, carbonation Filtration of the sodium hydrogen PEIP -- c a rbonate (solid phase) circulation soln. of the sintering chelate (liquid phase) Fig. 1